CSPC PHARMA (01093.HK) Latest Stock News - Major News Analysis - Longbridge

Quote List Quote List

Event Tracking

Dec12

Stone Pharmaceutical's Liposomal Irinotecan Injection Approved for First-Line Pancreatic Cancer Treatment

10:26

Dec10

Stone Pharmaceutical Group Secures FDA Approval for Weight Management Drug Trial

11:48

Sage Pharmaceutical Obtains Approval from FDA and NMPA to Initiate Clinical Trials for Act RIIA/IIB Monoclonal Antibody

10:18

Guoyuan International Gives SinoPharm Group a 'Buy' Rating, Optimistic About Innovative Drug R&D and Internationalization Strategy

03:51

Dec8

SJPH's Semaglutide Injection Application for Weight Management Approval Accepted by NMPA

09:47

Sino-Pharm SYH2069 Injection Receives FDA Approval for Clinical Trials in the US

00:53

Schedules & Filings

Schedules

Filings

Nov20

Earning Release(CST)

FY2025 Q3 Earning Release (HKD) Revenue 7.234 B, Net Income 1.053 B, EPS 0.0921

Nov18

Distribution Plan(CST)

Cash dividend 0.14 HKD

Oct20

Distribution Plan(CST)

Cash dividend 0.14 HKD

View More

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change

View More